Compare AKA & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKA | TMCI |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.7M | 144.0M |
| IPO Year | 2021 | 2021 |
| Metric | AKA | TMCI |
|---|---|---|
| Price | $11.11 | $1.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $24.33 | $4.21 |
| AVG Volume (30 Days) | 3.0K | ★ 617.2K |
| Earning Date | 03-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $595,281,000.00 | $218,879,000.00 |
| Revenue This Year | $5.57 | $3.30 |
| Revenue Next Year | $4.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.44 | ★ 7.90 |
| 52 Week Low | $7.00 | $1.86 |
| 52 Week High | $18.36 | $10.30 |
| Indicator | AKA | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 45.12 | 30.34 |
| Support Level | $10.52 | $2.02 |
| Resistance Level | $11.31 | $2.31 |
| Average True Range (ATR) | 0.36 | 0.16 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 17.38 | 5.80 |
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.